|
||
“Practices by cancer charity challenged.” By Robert Anglen, AZcentral.com The Breast Cancer Society describes itself as one of the few charities in the U.S. that provides direct help and assistance to those suffering from the disease. The 5-year-old organization reported taking in $52 million last year and spending $39 million on program services, which indicates . . . → Read More: “Practices by cancer charity challenged”
“Overtreatment Is Taking a Harmful Toll.” By Tara Parker-Pope, The New York Times When it comes to medical care, many patients and doctors believe more is better. But an epidemic of overtreatment — too many scans, too many blood tests, too many procedures — is costing the nation’s health care system at least $210 billion . . . → Read More: Overtreatment Is Taking a Harmful Toll
“Komen CEO’s Resignation Only Makes Critics Angrier.” By Holly Hall, The Chronicle of Philanthropy Susan G. Komen for the Cure may have hoped to halt a sharp drop in donations just ahead of its busy fall fundraising season, but instead it has made many disgruntled donors even angrier. The breast-cancer charity made big leadership changes . . . → Read More: Komen CEO’s Resignation Only Makes Critics Angrier
“Dr. Bernard Lown speaks out against overtreatment.” By Chelsea Conaboy, The Boston Globe Magazine Bernard Lown believes less medical treatment can sometimes be more. Convincing you and your doctor has become a mission for the 91-year-old cardiologist. CARDIOLOGIST DR. BERNARD LOWN had trouble sleeping. It was the early 1970s, and he and colleagues were trying . . . → Read More: Dr. Bernard Lown speaks out against overtreatment
“A Conversation with Dr. Patricia Steeg on Redesigning Clinical Trials to Test Therapies that Could Prevent Cancer Metastasis” National Cancer Institute Cancer Bulletin In a perspective published May 30 in Nature, Dr. Patricia Steeg argues that the current system for clinical trials must be redesigned if there is to be a decline in breast cancer . . . → Read More: A Conversation with Dr. Patricia Steeg on Redesigning Clinical Trials to Test Therapies that Could Prevent Cancer Metastasis
“The new religion: screening at your parish church.” By Charles Warlow, British Medical Journal Unusually for me, I went to church. On a Monday. Not to ask forgiveness or to sing a hymn, or to be instructed from the pulpit, but to be screened. After all, if Liverpool Anglican Cathedral can be a . . . → Read More: The new religion: screening at your parish church
“How doctors and patients do harm.” By Tara Parker-Pope, New York Times Well Blog Just how broken is the United States health care system? Dr. Otis Brawley, chief medical officer for the American Cancer Society, paints a grim picture in his new book written with Paul Goldberg, “How We Do Harm: A Doctor Breaks Ranks . . . → Read More: “How doctors and patients do harm”
“A teaching moment about politics and Komen.” By Samantha King, CNN When the Komen foundation bowed to pressure from anti-abortion activists to stop most of its funding of Planned Parenthood, the furor was swift and forceful. Komen’s decision was frequently described in the media and in the online outcry as a “betrayal” — of its . . . → Read More: A teaching moment about politics and Komen
“Why the Komen/Planned Parenthood Breakup—While It Lasted—Was Good for Feminism.” By Amy Schiller, The Nation It might not look like it at first, but Komen’s actions and the ensuing backlash are a huge boon for the feminist movement. The past decades have seen the rise of a nominally apolitical marketing campaign masquerading as feminism, . . . → Read More: Why the Komen/Planned Parenthood Breakup—While It Lasted—Was Good for Feminism |
||
| Copyright © 2026 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||